Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $6.6700 (-4.58%) ($6.5060 - $6.9700) on Tue. Aug. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.13% (three month average) | RSI | 50 | Latest Price | $6.6700(-4.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.8% a day on average for past five trading days. | Weekly Trend | ANPC advances 4.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(10%) IPO(10%) XLB(10%) LIT(9%) TLT(8%) | Factors Impacting ANPC price | ANPC will decline at least -4.065% in a week (0% probabilities). SHY(-26%) XLU(-11%) IBB(-9%) TBT(-8%) XLRE(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.065% (StdDev 8.13%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.92(-3.61%) | 10 Day Moving Average | $6.86(-2.77%) | 20 Day Moving Average | $6.37(4.71%) | To recent high | -15.8% | To recent low | 31% | Market Cap | $57m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |